LU85650A1 - Perfectionnements relatifs a des derives de cephalosporine - Google Patents

Perfectionnements relatifs a des derives de cephalosporine Download PDF

Info

Publication number
LU85650A1
LU85650A1 LU85650A LU85650A LU85650A1 LU 85650 A1 LU85650 A1 LU 85650A1 LU 85650 A LU85650 A LU 85650A LU 85650 A LU85650 A LU 85650A LU 85650 A1 LU85650 A1 LU 85650A1
Authority
LU
Luxembourg
Prior art keywords
cephalexin
monohydrate
solvate
hydrochloride
crystalline
Prior art date
Application number
LU85650A
Other languages
English (en)
French (fr)
Inventor
Joseph Michael Indelicato
Gary Lowell Engel
Harry Albert Rose
Lawrence Joseph Mcshane
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU85650A1 publication Critical patent/LU85650A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU85650A 1983-12-01 1984-11-27 Perfectionnements relatifs a des derives de cephalosporine LU85650A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55688783 1983-12-01
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate

Publications (1)

Publication Number Publication Date
LU85650A1 true LU85650A1 (fr) 1985-07-17

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85650A LU85650A1 (fr) 1983-12-01 1984-11-27 Perfectionnements relatifs a des derives de cephalosporine

Country Status (46)

Country Link
US (1) US4600773A (pl)
EP (1) EP0143658B1 (pl)
JP (1) JPS60132990A (pl)
KR (1) KR870000527B1 (pl)
AT (1) AT390616B (pl)
AU (1) AU566080B2 (pl)
BE (1) BE901142A (pl)
BG (1) BG40966A3 (pl)
BR (1) BR8406037A (pl)
CH (1) CH661732A5 (pl)
CS (1) CS248725B2 (pl)
CY (1) CY1505A (pl)
DD (1) DD229410A5 (pl)
DE (1) DE3443065A1 (pl)
DK (1) DK158354C (pl)
ES (1) ES538019A0 (pl)
FI (1) FI80274C (pl)
FR (1) FR2555990B1 (pl)
GB (1) GB2150566B (pl)
GR (1) GR81043B (pl)
GT (1) GT198400146A (pl)
HK (1) HK92089A (pl)
HU (1) HU192516B (pl)
IE (1) IE57886B1 (pl)
IL (1) IL73639A (pl)
IN (1) IN163078B (pl)
IT (1) IT1177329B (pl)
JO (1) JO1347B1 (pl)
LU (1) LU85650A1 (pl)
MA (1) MA20279A1 (pl)
MX (1) MX159670A (pl)
MY (1) MY102966A (pl)
NL (1) NL8403588A (pl)
NO (1) NO844711L (pl)
NZ (1) NZ210357A (pl)
OA (1) OA07876A (pl)
PH (1) PH20849A (pl)
PL (1) PL146014B1 (pl)
PT (1) PT79553B (pl)
SE (1) SE464026B (pl)
SG (1) SG59789G (pl)
SU (1) SU1251807A3 (pl)
YU (1) YU45680B (pl)
ZA (1) ZA849224B (pl)
ZM (1) ZM6384A1 (pl)
ZW (1) ZW19084A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (pl) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
SG59789G (en) 1989-12-29
JPH0548234B2 (pl) 1993-07-20
DD229410A5 (de) 1985-11-06
FI844631L (fi) 1985-06-02
IE843033L (en) 1985-06-01
DK158354B (da) 1990-05-07
IL73639A (en) 1988-06-30
FI844631A0 (fi) 1984-11-26
JO1347B1 (en) 1986-11-30
FI80274C (fi) 1990-05-10
HUT35685A (en) 1985-07-29
PH20849A (en) 1987-05-08
SU1251807A3 (ru) 1986-08-15
NZ210357A (en) 1988-05-30
FR2555990B1 (fr) 1986-12-26
AT390616B (de) 1990-06-11
DE3443065A1 (de) 1985-06-20
GB2150566A (en) 1985-07-03
DK561284A (da) 1985-06-02
GB2150566B (en) 1987-08-26
JPS60132990A (ja) 1985-07-16
KR850004765A (ko) 1985-07-27
IT8423746A0 (it) 1984-11-27
ATA373284A (de) 1989-11-15
GR81043B (en) 1985-03-27
IE57886B1 (en) 1993-05-05
FR2555990A1 (fr) 1985-06-07
AU566080B2 (en) 1987-10-08
FI80274B (fi) 1990-01-31
BE901142A (fr) 1985-05-28
KR870000527B1 (ko) 1987-03-14
IT1177329B (it) 1987-08-26
PL250593A1 (en) 1985-07-30
MA20279A1 (fr) 1985-07-01
ZW19084A1 (en) 1985-06-12
NL8403588A (nl) 1985-07-01
EP0143658A2 (en) 1985-06-05
CH661732A5 (de) 1987-08-14
NO844711L (no) 1985-06-03
MX159670A (es) 1989-08-02
DE3443065C2 (pl) 1989-03-23
SE8405954L (sv) 1985-06-02
DK561284D0 (da) 1984-11-27
PT79553A (en) 1984-12-01
CS248725B2 (en) 1987-02-12
EP0143658B1 (en) 1989-03-22
DK158354C (da) 1990-10-01
GT198400146A (es) 1986-05-20
IT8423746A1 (it) 1986-05-27
HK92089A (en) 1989-11-24
YU199684A (en) 1987-02-28
IN163078B (pl) 1988-08-06
PT79553B (en) 1986-12-15
ZM6384A1 (en) 1985-07-22
YU45680B (sh) 1992-07-20
ES8602011A1 (es) 1985-11-01
SE8405954D0 (sv) 1984-11-26
SE464026B (sv) 1991-02-25
IL73639A0 (en) 1985-02-28
GB8430073D0 (en) 1985-01-09
CY1505A (en) 1990-08-03
AU3589784A (en) 1985-06-06
MY102966A (en) 1993-03-31
ZA849224B (en) 1986-07-30
PL146014B1 (en) 1988-12-31
HU192516B (en) 1987-06-29
BR8406037A (pt) 1985-08-27
BG40966A3 (en) 1987-03-14
OA07876A (fr) 1986-11-20
EP0143658A3 (en) 1986-02-12
ES538019A0 (es) 1985-11-01
US4600773A (en) 1986-07-15

Similar Documents

Publication Publication Date Title
BE1005921A4 (fr) Utilisation en therapeutique des antagonistes des recepteurs serotoninergiques 5ht3.
EP1592401B1 (en) Process for modifying drug crystal formation of mycophenolate sodium salt
FR2493322A1 (fr) Hydrates cristallins de tosylate de (d-a-amino a-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle utiles comme medicaments antimicrobiens et procedes de leur preparation
EP1896439B1 (en) Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
LU85650A1 (fr) Perfectionnements relatifs a des derives de cephalosporine
JPS62181248A (ja) ２−（２−アミノチアゾリル）−２−ヒドロキシイミノ酢酸誘導体及びその製造法
JP4015954B2 (ja) トシル酸スプラタスト結晶
TWI250162B (en) Beta-lactamase inhibitor prodrug
CA1094547A (fr) Procede de preparation de derives de l'acide 3- carbamoyloxymethyl 7-(amino thiazolyl acetamido) cephalosporanique
FR2491474A1 (fr) Napsylate de (d-a-amino a-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle cristallin et ses formes hydratees, leurs procedes de preparation et des medicaments antimicrobiens les contenant comme produits actifs
EP1682124B1 (fr) Compositions pharmaceutiques a base de sel d'idazoxan ou d´un de ses polymorphes
FR2976284A1 (fr) Nouveaux co-cristaux d'agomelatine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CH615673A5 (pl)
EP0384088B1 (fr) La (+) 1-[(3,4,5-triméthoxy) benzyloxyméthyl]-1-phényl-N,N-diméthyl-n-propylamine, son procédé de préparation et son application en thérapeutique
EP1007522B1 (fr) 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
JPS5813556A (ja) 新規な光学活性ジペプチド
JPH03501387A (ja) ケトブチロラクトン及びフリルブチロラクトンを用いて哺乳類の炎症を治療する方法
FR2690917A1 (fr) Aminoesters, leur procédé de préparation et leur application en thérapeutique.
JPH0567128B2 (pl)
JP3112754B2 (ja) シクロアルケノン化合物及び該化合物を有効成分とする脳機能改善薬
FR2480602A1 (fr) Hexahydro-pyrimido(1,2-a)azepines 3-substituees a titre de medicaments
FR2598417A1 (fr) Esters d'azoniaspironortropanols, procede pour leur preparation et medicaments les contenant
BE858069A (fr) Composition anticancereuse et son utilisation
LU85410A1 (fr) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanols et leur preparation